Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
| dc.rights.license | open | en_US |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| dc.contributor.author | ACCOCEBERRY, Isabelle
IDREF: 075520818 | |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| hal.structure.identifier | Université de Bordeaux [UB] | |
| dc.contributor.author | COUZIGOU, Celia | |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| dc.contributor.author | FITTON-OUHABI, Valerie | |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| dc.contributor.author | BITEAU, Nicolas | |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| dc.contributor.author | NOEL, Thierry | |
| dc.date.accessioned | 2023-11-21T14:07:41Z | |
| dc.date.available | 2023-11-21T14:07:41Z | |
| dc.date.issued | 2019-03-01 | |
| dc.identifier.issn | 1460-2091 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/186017 | |
| dc.description.abstractEn | A strain of the opportunistic pathogenic yeast Candida lusitaniae was genetically engineered for full-length replacement of the FKS1 gene encoding the target of echinocandin antifungals in order to assess the impact of FKS mutations on echinocandin resistance and reduced echinocandin susceptibility (RES). FKS1 allelic exchange was achieved by transforming C. lusitaniae with two DNA fragments covering the entire FKS1 ORF. Both fragments overlap a 40 bp region where SNPs or small indels of interest were inserted. To target integration at the FKS1 locus, each DNA fragment was fused with split auxotrophic markers of which complementary truncated parts were previously inserted into the chromosomal regions flanking FKS1, allowing selection on minimal medium. Three SNPs described in the FKS1 hotspot (HS) regions HS1 or HS2 of clinical isolates of Candida albicans were expressed at an equivalent position in C. lusitaniae and were confirmed to confer either reduced susceptibility (F641V) or full resistance (S645P and R1361G) to caspofungin. The F659 deletion reported in an FKS2 allele of Candida glabrata and the naturally occurring P660A substitution in FKS1 of Candida parapsilosis were shown to confer a 256-fold and 6-fold increase in caspofungin MIC, respectively, when introduced into an FKS1 allele of C. lusitaniae. We have successfully developed a C. lusitaniae strain for the expression of full-length FKS1 alleles harbouring known mutations contributing to reduced susceptibility or resistance to caspofungin, thus opening the way for the screening of other FKS1/FKS2 mutations potentially involved in RES. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Alleles | |
| dc.subject.en | Antifungal Agents | |
| dc.subject.en | Candida | |
| dc.subject.en | Caspofungin | |
| dc.subject.en | Drug Resistance | |
| dc.subject.en | Fungal | |
| dc.subject.en | Glucosyltransferases | |
| dc.subject.en | Microbial Sensitivity Tests | |
| dc.subject.en | Polymorphism | |
| dc.subject.en | Single Nucleotide | |
| dc.subject.en | Recombination | |
| dc.subject.en | Genetic | |
| dc.title.en | Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae. | |
| dc.title.alternative | J Antimicrob Chemother | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1093/jac/dky475 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Microbiologie et Parasitologie | en_US |
| dc.identifier.pubmed | 30517635 | en_US |
| bordeaux.journal | Journal of Antimicrobial Chemotherapy | en_US |
| bordeaux.page | 618-624 | en_US |
| bordeaux.volume | 74 | en_US |
| bordeaux.hal.laboratories | MFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234 | en_US |
| bordeaux.issue | 3 | en_US |
| bordeaux.institution | CNRS | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | pubmed | |
| hal.identifier | hal-04297934 | |
| hal.version | 1 | |
| hal.date.transferred | 2023-11-21T14:07:44Z | |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | true | |
| workflow.import.source | pubmed | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Antimicrobial%20Chemotherapy&rft.date=2019-03-01&rft.volume=74&rft.issue=3&rft.spage=618-624&rft.epage=618-624&rft.eissn=1460-2091&rft.issn=1460-2091&rft.au=ACCOCEBERRY,%20Isabelle&COUZIGOU,%20Celia&FITTON-OUHABI,%20Valerie&BITEAU,%20Nicolas&NOEL,%20Thierry&rft.genre=article |
